Correlation Between Cue Biopharma and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Viking Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Viking Therapeutics.
Diversification Opportunities for Cue Biopharma and Viking Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cue and Viking is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Viking Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Viking Therapeutics. In addition to that, Cue Biopharma is 1.69 times more volatile than Viking Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Viking Therapeutics is currently generating about -0.25 per unit of volatility. If you would invest 7,175 in Viking Therapeutics on August 31, 2024 and sell it today you would lose (1,724) from holding Viking Therapeutics or give up 24.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Viking Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Viking Therapeutics |
Cue Biopharma and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Viking Therapeutics
The main advantage of trading using opposite Cue Biopharma and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Tff Pharmaceuticals | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |